Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen
Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen · Investor's Business Daily

In This Article:

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.